Prostate Cancer Cells Synergistically Defend Against CD8⁺ T Cells by Secreting Exosomal PD-L1

Western blotting and immunofluorescence were performed to compare programmed necrosis ligand 1 (PD-L1) levels in exosomes derived from different prostate cancer cells.